Stanley-Laman Group’s Chemed CHE Stock Holding History

Stanley-Laman Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-471	Closed	-$221K	–	241
2022 Q2	$221K	Buy	+471	New	+$230K	0.04%	248

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stanley-Laman Group's CHE Position: Q3 2022 in Review

Stanley-Laman Group sold out of Chemed (CHE) in Q3 2022, closing a stake of 471 shares — an estimated $221K sold.

Stanley-Laman Group first reported a position in CHE in Q2 2022 and held it in 1 quarter. The position peaked at $221K in Q2 2022. 419 funds tracked by Wall St. Rank hold CHE as of Q3 2022.

Stanley-Laman Group reported no remaining Chemed position as of Q3 2022 after selling out during the quarter.
Stanley-Laman Group sold 471 Chemed shares in Q3 2022, an estimated $221K.
Stanley-Laman Group first reported a position in Chemed in Q2 2022 and held it in 1 quarter.
Stanley-Laman Group's Chemed position peaked at $221K in Q2 2022.
419 funds tracked by Wall St. Rank held Chemed as of Q3 2022.

Based on Stanley-Laman Group's 13F filing for Q3 2022, filed 18 Oct 2022.